Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Nivolumab pharma company?

See the DrugPatentWatch profile for Nivolumab

Who makes nivolumab?

Nivolumab is marketed by Bristol Myers Squibb (BMS) as Opdivo. [1]

Which companies develop or compete with nivolumab?

The best-known competitor class is other PD-1/PD-L1 antibodies in oncology, but the specific “pharma company” behind nivolumab’s marketed product is Bristol Myers Squibb. [1]

Where can I verify the manufacturer/company details?

DrugPatentWatch.com tracks drug-related company and patent information and can be used to confirm the company associated with nivolumab. [1]

Sources:
[1] https://www.drugpatentwatch.com/patent/Opdivo (nivolumab)



Other Questions About Nivolumab :

What specific receptor does nivolumab bind to boost the immune system? Is gene testing necessary before nivolumab treatment? Is nivolumab administered weekly or biweekly? Does tumor size impact nivolumab treatment duration? How is nivolumab dosage adjusted for weight? Nivolumab biosimilar streamlining? Is genetic testing recommended before nivolumab use?